What's Going On With Autonomix Medical Stock Monday?
What's Going On With Autonomix Medical Stock Monday?
Autonomix Medical, Inc. (NASDAQ:AMIX) shares are moving higher on Monday after the company announced it was granted a U.S. patent titled Systems and Methods for Treating Cancer and/or Augmenting Organ Function.
Autonomix 醫療公司（納斯達克：AMIX）股票在週一上漲，此前該公司宣佈獲得了一項名爲「治療癌症和/或增強器官功能的系統和方法」的美國專利。
What To Know: The patent encompasses technology for systems, methods and devices designed to treat cancerous tumors and manage cancer-related pain through interventional techniques. The company is first focusing on developing its technology to treat pain associated with pancreatic cancer.
需要了解的是：該專利涵蓋了旨在通過介入技術治療癌症腫瘤和管理癌症相關疼痛的系統、方法和設備。公司首先專注於開發其技術以治療與胰腺癌相關的疼痛。
In a previously conducted preclinical mouse study, the company demonstrated that targeted nerve ablation resulted in a statistically significant reduction of metastases and tumor mass. While Autonomix is currently conducting a human clinical trial focused on pain reduction using this technology, it plans to explore in future studies whether this ablation technology can also slow pancreatic cancer growth and metastasis.
在之前進行的臨牀前小鼠研究中，該公司證明了靶向神經消融能顯著減少轉移和腫瘤質量。雖然Autonomix當前正在進行一項人體臨牀試驗，重點是使用該技術減輕疼痛，但它計劃在未來的研究中探討這種消融技術是否也能減緩胰腺癌的生長和轉移。
Related Link: Why Is White Label Technology Company SMX Stock Surging On Monday?
相關鏈接：爲什麼白標科技公司SMX股票在週一激增？
AMIX Price Action: At the time of publication, Autonomix stock is trading 18.8% higher at $3.92, according to data from Benzinga Pro.
AMIX價格動態：在發佈時，根據Benzinga Pro的數據，Autonomix股票上漲18.8%，報$3.92。
Image: Image: Akava Photo from Pixabay
圖片：來自Pixabay的Akava照片
